Global Cervical Cancer Test Market Projections, Primary and Secondary Research, SWOT Analysis, Segmentation and Forecast by 2022

July 26 07:36 2017

Orbis Research
OrbisResearch.com has published new research report on “Global Cervical Cancer Test Market and Screening Population Analysis, By Screening Type (Pap Smear, HPV DNA, VIA)-Global Forecast to 2022” to its database.

Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world. In most cases, the disease is attributed to genital Human Papilloma Virus (HPV) infection. As cervical cancer is a disease with long latent period, early detection and treatment of precancerous lesions is known to be highly effective in women who regularly participate in screening programs. The death rate due to cervical cancer has dropped in many developed countries, thus indicating the growing adoption of screening procedures, such as Pap test and HPV testing.

Browse the report: http://www.orbisresearch.com/reports/index/cervical-cancer-test-market-and-screening-population-analysis-by-screening-type-pap-smear-hpv-dna-via-global-forecast-to-2022

The cervical cancer test market is driven by growth in aging female population and rising prevalence rate of cervical cancer, high incidence rate of HPV infections, rising incidences of teenage sexual cases, increasing number of awareness programs for cervical cancer screening, introduction of low cost VIA test and government initiatives and funding. However, lack of healthcare infrastructure and awareness regarding cervical cancer screening are the major restraints for cervical cancer testing market.

Key Highlights of the Report
Cervical cancer is amongst one of the most common causes of deaths in the U.S. women. United States alone captured over 40 percent share of the global cervical cancer test market.
Pap test held a majority share of the cervical cancer screening market on account of the high efficiency of this test, however, HPV test is steadily gaining prominence.
VIA is the best screening option where access to Pap smear tests and HPV test is not available.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/360138

In 2016, Global cervical cancer test population was estimated at XXX Million.
Cervical cancer incidence rate in Europe is estimated at 10.6 per 100,000 women population.
Asia Pacific and North American region are competing closely with each other to grab maximum share of the cervical cancer test population.
Indonesia, China, India and Japan captures highest share of the Asian cervical cancer test population.
North America captures highest share of the global cervical cancer test market followed by the European region.
Germany, United Kingdom and France are the other top three leaders in cervical cancer test market.
China and India are the top contributor to the VIA test market.
Australia’s National Cervical Cancer Screening Program will change from December 2017.

iGATE RESEARCH report titled “Cervical Cancer Test Market & Screening Population Analysis, By Screening Type (Pap Smear, HPV DNA, VIA) – Global Forecast to 2022” is a 306 Page report with 238 Figures and 25 Tables. This report provides a comprehensive assessment of the Cervical Cancer Test (Pap Smear, HPV DNA Test and VIA) Screening Market in terms of Value and Volume terms.

The 20 Countries covered in the report have been analyzed from 4 View Points:
1. Cervical Cancer Test Population (2007 – 2022)
Pap Smear Test Population (2007 – 2022)
HPV DNA Test population (2007 – 2022)
VIA Test Population (2007 – 2022)

2. Cervical Cancer Mortality

3. Cervical Cancer Test Market (2007 – 2022)
Pap Smear Test Market (2007 – 2022)
HPV DNA Test Market (2007 – 2022)
VIA Test Market (2007 – 2022)

4. Global Cervical Cancer Test Market – Driving Factors and Challenges

Cervical Cancer Test Market & Screening Population Analysis – 20 Countries Covered
1. United States
2. Canada
3. United Kingdom
4. France
5. Germany
6. Italy
7. Spain
8. Sweden
9. Switzerland
10. Norway
11. Netherlands
12. Japan
13. South Korea
14. Singapore
15. Malaysia
16. Australia
17. India
18. China
19. Thailand
20. Indonesia

Buy the [email protected]http://www.orbisresearch.com/contact/purchase/360138

Data Sources
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

List of Tables:
Table 5-1: By Region – Cervical Cancer Test Population Share (Percent)
Table 5-2: By Region – Forecast for Cervical Cancer Test Population Share (Percent)
Table 5-3: Global – Cervical Cancer Test Population Share (Percent)
Table 5-4: Global – Forecast for Cervical Cancer Test Population Share (Percent)
Table 6-1: By Region – Cervical Cancer Test Market Share (Percent)
Table 6-2: By Region – Forecast for Cervical Cancer Test Market Share (Percent)
Table 6-3: Global – Cervical Cancer Test Market Share (Percent)
Table 6-4: Global – Forecast for Cervical Cancer Test Market Share (Percent)
Table 6-5: Global – Cervical Cancer Pap Smear Test Market Share (Percent)
Table 6-6: Global – Forecast for Cervical Cancer Pap Smear Test Market Share (Percent)
Table 6-7: Global – Cervical Cancer HPV DNA Test Market Share (Percent)
Table 6-8: Global – Forecast for Cervical Cancer HPV DNA Test Market Share (Percent)
Table 6-9: Global – Cervical Cancer VIA Test Market Share (Percent)
Table 6-10: Global – Forecast for Cervical Cancer VIA Test Market Share (Percent)

List of Figures:
Figure 2-1: Global – Cervical Cancer Test Population (Million)
Figure 2-2: Global – Forecast for Cervical Cancer Test Population (Million)
Figure 2-3: North America – Cervical Cancer Test Population (Million)
Figure 2-4: North America – Forecast for Cervical Cancer Test Population (Million)
Figure 2-5: Europe – Cervical Cancer Test Population (Million)
Figure 2-6: Europe – Forecast for Cervical Cancer Test Population (Million)
Figure 2-7: Asia Pacific – Cervical Cancer Test Population (Million)
Figure 2-8: Asia Pacific – Forecast for Cervical Cancer Test Population (Million)
Figure 3-1: Global – Cervical Cancer Test Market (Million US$)
Figure 3-2: Global – Forecast for Cervical Cancer Test Market (Million US$)
Figure 3-3: North America – Cervical Cancer Test Market (Million US$)
Figure 3-4: North America – Forecast for Cervical Cancer Test Market (Million US$)
Figure 3-5: Europe – Cervical Cancer Test Market (Million US$)

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Media Contact
Company Name: Orbis Research
Contact Person: Hector Costello
Email: Send Email
Phone: +1 (214) 884-6817
Address:4144N Central Expressway, Suite 600
City: Dallas
State: Texas
Country: United States
Website: http://www.orbisresearch.com/reports/index/cervical-cancer-test-market-and-screening-population-analysis-by-screening-type-pap-smear-hpv-dna-via-global-forecast-to-2022

  Categories: